ASO Visual Abstract: Rates of Pathologic Complete Response and Overall Survival in Patients with Inflammatory Breast Cancer-A National Cancer Database Study

被引:0
|
作者
Parrish, Kendra M. [1 ,3 ]
Thomas, Samantha M. [2 ,3 ]
Cartwright, Sara B. [4 ]
van den Bruele, Astrid Botty [1 ,3 ]
Zasloff, Rebecca [5 ]
Dilalla, Gayle A. [1 ,3 ]
Dinome, Maggie L. [1 ,3 ]
Menendez, Carolyn S. [1 ,3 ]
Rosenberger, Laura H. [1 ,3 ]
Woriax, Hannah E. [1 ,3 ]
Hwang, E. Shelley [1 ,3 ]
Plichta, Jennifer K. [1 ,3 ]
Chiba, Akiko [1 ,3 ]
机构
[1] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA
[2] Duke Univ, Sch Med, Dept Biostat & Bioinformat, Durham, NC USA
[3] Duke Univ, Duke Canc Inst, Med Ctr, Durham, NC 27710 USA
[4] Univ Nebraska Med Ctr, Dept Surg, Omaha, NE USA
[5] Duke Univ, Sch Med, Durham, NC USA
关键词
D O I
10.1245/s10434-024-16206-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:8912 / 8913
页数:2
相关论文
共 50 条
  • [31] ASO Visual Abstract: Lymphedema in Inflammatory Breast Cancer Patients Following Trimodal Treatment
    Clara R. Farley
    Shelby Irwin
    Taiwo Adesoye
    Susie X. Sun
    Sarah M. DeSnyder
    Anthony Lucci
    Simona F. Shaitelman
    Edward I. Chang
    Naoto T. Ueno
    Wendy A. Woodward
    Mediget Teshome
    Annals of Surgical Oncology, 2022, 29 : 6379 - 6380
  • [32] ASO Visual Abstract: Current Surgical Management of Inflammatory Breast Cancer
    T. Adesoye
    A. Lucci
    Annals of Surgical Oncology, 2021, 28 : 618 - 618
  • [33] ASO Visual Abstract: Current Surgical Management of Inflammatory Breast Cancer
    Adesoye, T.
    Lucci, A.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 3) : 618 - 618
  • [34] ASO Author Reflections: Inflammatory Breast Cancer: Durable Breast Cancer-Specific Survival for HER2-Positive Patients with a Pathologic Complete Response to Neoadjuvant Therapy
    Tina J. Hieken
    Tanya L. Hoskin
    Annals of Surgical Oncology, 2022, 29 : 597 - 598
  • [35] ASO Author Reflections: Inflammatory Breast Cancer: Durable Breast Cancer-Specific Survival for HER2-Positive Patients with a Pathologic Complete Response to Neoadjuvant Therapy
    Hieken, Tina J.
    Hoskin, Tanya L.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 3) : 597 - 598
  • [36] ASO Visual Abstract: The Validity of Using Pathological Response as a Surrogate for Overall Survival in Neoadjuvant Studies for Esophageal Cancer-A Systematic Review and Meta-analysis
    Su, Feng
    Yang, Xinyu
    Yin, Jun
    Shen, Yaxing
    Tan, Lijie
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (04) : 2523 - 2524
  • [37] Overall survival outcomes in older patients with metastatic breast cancer: A National Cancer Database analysis
    Patel, Rima
    Kwon, Deukwoo
    Tiersten, Amy
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [38] Racial/Ethnic Disparities in Rates of Pathological Complete Response and Survival in Patients with Inflammatory Breast Cancer
    Zasloff, Rebecca
    Thomas, Samantha
    Parrish, Kendra
    van de Bruele, Astrid Botty
    DiLalla, Gayle
    DiNome, Maggie
    Rosenberger, Laura
    Woriax, Hannah
    Hwang, E. Shelley
    Plichta, Jennifer
    Chiba, Akiko
    CANCER RESEARCH, 2024, 84 (09)
  • [39] ASO Visual Abstract: Serum Enzymes and Pathologic Complete Response to the Addition of Targeted Therapy in Neoadjuvant Chemotherapy for HER2-Positive Breast Cancer Patients
    Chen, Zongshun
    Zhang, Jing
    Chen, Wei
    Chen, Xueyi
    Lu, Da-Lin
    Li, Junjie
    ANNALS OF SURGICAL ONCOLOGY, 2025, : 4061 - 4062
  • [40] Axillary Pathologic Complete Response in Inflammatory Breast Cancer Patients: Implications for SLNB?
    Imeokparia, Folasade O.
    Hughes, Tasha M.
    Dossett, Lesly A.
    Jeruss, Jacqueline S.
    Chang, Alfred E.
    Sabel, Michael S.
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (10) : 3374 - 3379